ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Hybrid

International Cancer Conference Journal

Acronym:iccj
•
Identifier (ISSN):2192-3183(Print)
•
Publisher:Springer Japan
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.4↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for International Cancer Conference Journal

WoS Q4
00110.720230.520240.520250.42026
Annual Impact Factor Metric
Current (2026):0.4
Scopus SJR & Rank
N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data
H-Index (Hirsch Index)
N/A

papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
61articles/year
12.24% Gold OA•87.1% Original Research

Aims & Scope

This online-only journal publishes original case reports on all types of cancer. In particular, we welcome not only case reports of educational value in the diagnosis and treatment of cancers, but also reports on molecularly analyzed cancer cases, including gene mutations, gene fusions, gene expression, and changes in copy number, regardless of their known clinical significance. Assessing the molecular analysis of a tumor usually requires a “cancer conference” in which experts from various fields discuss it. Even if the authors and their respective “cancer conference” were unable to determine the clinical significance of molecular changes at the time of submission and publication, their data may provide evidence that will help the scientific community develop precision medicine solutions in the future. We welcome case reports with reviews of the literature on similar cases, as they are more useful and valuable to readers than are reports of rare cases. International Cancer Conference Journal is the official publication of the Japan Society of Clinical Oncology (JSCO). - Presents an online-only collection of original case reports on all types of cancer - In particular, welcomes molecularly analyzed cancer cases - The Official Publication of the Japan Society of Clinical Oncology (JSCO)

Topics Covered (Recognized by AI)
Medicine98.8%Biology97.4%Internal medicine96.7%Genetics91.4%Surgery84.7%Pathology77.3%Cancer72%Radiology62.7%Oncology44.5%Chemotherapy40%Immunology36.4%Endocrinology29.2%Gastroenterology27%Chemistry26.5%Anatomy23.7%Metastasis23.5%Psychology23.2%Biochemistry22.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

ONCOLOGY

Q4
Rank322/333
IndexESCI
JCIESCI2026

ONCOLOGY

Q4
Rank316/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.4
Articles / Year59
Total Citations4
2025
IF0.5
Articles / Year97
Total Citations60
2024
IF0.5
Articles / Year97
Total Citations137
2023
IF0.7
Articles / Year51
Total Citations85
2022
IF—
Articles / Year64
Total Citations173

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Cancer Conference Journal (acronym: iccj, ISSN: 2192-3183) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by Springer Japan in Japan. The periodical holds a Journal Impact Factor (JIF) of 0.40, ranking in quartile Q4 of Web of Science (ESCI).

The journal enforces rigorous peer evaluation with a publication frequency of 4 issues per year, an annual output of approximately 61 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Japan
Publication Language
English
Frequency
4 issues per year
Indexing & Databases
ESCIPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e692f283-7413-40a8-bded-6f6a505cfc8c
Database Updated: 2026-10-01